Literature DB >> 10329550

Limitation of Tat-associated transcriptional processivity in HIV-infected PBMC.

M Adams1, C Wong, D Wang, J Romeo.   

Abstract

The ability of HIV to match levels of viral mRNA to the activation state of the host cell may play a role in its ability to persist as well as to replicate. This linkage depends on the function of the viral transcriptional regulatory protein, Tat, which increases the efficiency of RNA elongation (transcriptional processivity) in response to cellular activation. To quantify levels of Tat function in vivo, a quantitative competitive RT-PCR assay was developed that reflects levels of TAR leader fragments (nonprocessive transcripts) and viral mRNA (processive transcripts), indicating low or high levels of Tat function, respectively. The abundance of these RNA species was measured in peripheral blood mononuclear cells (PBMC) of 22 HIV-1-positive individuals (CD4(+) T cell counts 63-934/mm3) and in established cell line models of HIV constitutive replication (H9IIIB) and reversible latency (U1 and ACH-2). In PBMC, the level of total viral transcripts ranged over four orders of magnitude; however, nonprocessive transcription predominated: 70% of PBMC samples had a ratio of processive to total transcripts of <0.3 and none of the samples had 100% processivity. The cell line studies revealed that, even in activated H9IIIB cells, nonprocessive transcription dominates and that latently infected cells can have different transcriptional responses to activation. This is the first study that enumerates degrees of transcriptional processivity in the circulating mononuclear cell compartment and the results suggest that limitation of Tat function may be a common phenotype throughout the course of the disease. Copyright 1999 Academic Press.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10329550     DOI: 10.1006/viro.1999.9647

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  10 in total

Review 1.  HIV-specific CD8⁺ T cells and HIV eradication.

Authors:  R Brad Jones; Bruce D Walker
Journal:  J Clin Invest       Date:  2016-01-05       Impact factor: 14.808

2.  Sulfonation pathway inhibitors block reactivation of latent HIV-1.

Authors:  Jeffrey P Murry; Joseph Godoy; Amey Mukim; Justine Swann; James W Bruce; Paul Ahlquist; Alberto Bosque; Vicente Planelles; Celsa A Spina; John A T Young
Journal:  Virology       Date:  2014-10-11       Impact factor: 3.616

3.  HIV latency in isolated patient CD4+ T cells may be due to blocks in HIV transcriptional elongation, completion, and splicing.

Authors:  Steven A Yukl; Philipp Kaiser; Peggy Kim; Sushama Telwatte; Sunil K Joshi; Mai Vu; Harry Lampiris; Joseph K Wong
Journal:  Sci Transl Med       Date:  2018-02-28       Impact factor: 17.956

4.  Assays for precise quantification of total (including short) and elongated HIV-1 transcripts.

Authors:  Philipp Kaiser; Sunil K Joshi; Peggy Kim; Peilin Li; Hongbing Liu; Andrew P Rice; Joseph K Wong; Steven A Yukl
Journal:  J Virol Methods       Date:  2016-12-27       Impact factor: 2.014

5.  Analysis of human immunodeficiency virus type 1 transcriptional elongation in resting CD4+ T cells in vivo.

Authors:  Kara G Lassen; Justin R Bailey; Robert F Siliciano
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

6.  Loss of the Brm-type SWI/SNF chromatin remodeling complex is a strong barrier to the Tat-independent transcriptional elongation of human immunodeficiency virus type 1 transcripts.

Authors:  Taketoshi Mizutani; Aya Ishizaka; Mariko Tomizawa; Takuya Okazaki; Nobutake Yamamichi; Ai Kawana-Tachikawa; Aikichi Iwamoto; Hideo Iba
Journal:  J Virol       Date:  2009-09-02       Impact factor: 5.103

7.  Nuclear retention of multiply spliced HIV-1 RNA in resting CD4+ T cells.

Authors:  Kara G Lassen; Kasra X Ramyar; Justin R Bailey; Yan Zhou; Robert F Siliciano
Journal:  PLoS Pathog       Date:  2006-07       Impact factor: 6.823

8.  The Tat Inhibitor Didehydro-Cortistatin A Prevents HIV-1 Reactivation from Latency.

Authors:  Guillaume Mousseau; Cari F Kessing; Rémi Fromentin; Lydie Trautmann; Nicolas Chomont; Susana T Valente
Journal:  MBio       Date:  2015-07-07       Impact factor: 7.867

9.  ZASC1 stimulates HIV-1 transcription elongation by recruiting P-TEFb and TAT to the LTR promoter.

Authors:  James W Bruce; Rachel Reddington; Elizabeth Mathieu; Megan Bracken; John A T Young; Paul Ahlquist
Journal:  PLoS Pathog       Date:  2013-10-24       Impact factor: 6.823

10.  T-cell responses targeting HIV Nef uniquely correlate with infected cell frequencies after long-term antiretroviral therapy.

Authors:  Allison S Thomas; Kimberley L Jones; Rajesh T Gandhi; Deborah K McMahon; Joshua C Cyktor; Dora Chan; Szu-Han Huang; Ronald Truong; Alberto Bosque; Amanda B Macedo; Colin Kovacs; Erika Benko; Joseph J Eron; Ronald J Bosch; Christina M Lalama; Samuel Simmens; Bruce D Walker; John W Mellors; R Brad Jones
Journal:  PLoS Pathog       Date:  2017-09-20       Impact factor: 6.823

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.